A more robust interferon-gamma (IFN-γ)-dominated CD4+ T-cell response was correlated with improved recovery from JE clinical outcomes, with the potential capacity to recognize non-DIIFL regions of the E proteins (69). The gene discussed is CD4; the disease is Japanese encephalitis.